Tag: biotechnology
-
Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies
Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types.
-
Trial Testing Cancer Treatment Delivery Compound
A compound designed to help cancer therapies better penetrate and kill solid tumors is being tested in its first clinical trial among patients with pancreatic cancer.
-
New Antibiotics Discovered in Stomach Peptides
Researchers in Italy and the U.S. found a potential source of new antibiotics in derivatives of peptides used by the digestive process in the stomach.
-
Bread Wheat Genome Sequenced
An international collaboration published a complete, annotated genomic sequencing of wheat used in making bread, a widely grown staple crop and major source of nutrition worldwide.
-
Pfizer, Biotech Partner on RNA Flu Vaccine
A biotechnology company in Germany and drug maker Pfizer are developing a vaccine to prevent seasonal influenza using messenger RNA that instructs cells on production of proteins.
-
Peptide Pain Drugs in Development Aimed at Alternative Targets
Pain drugs made from peptides, small protein-like compounds, and guided by antibodies are being developed as alternatives to prescription opioids to treat moderate to severe pain.
-
FDA Approves RNA-Interference Nerve Disease Therapy
A treatment that silences the actions of RNA and reverses damage to nerves from a rare inherited neurological disease was approved by the Food and Drug Administration.
-
Cancer Drug Delivery Through Milk Particles Under Study
A new research project is investigating components in raw cow’s milk that could make it possible to give chemotherapy for cancer as oral drugs rather than infusions.
-
Start-Up Developing Regenerative Liver Disease Treatments
A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions.
-
Allergan Licensing Crispr for Inherited Eye Disease
Drug maker Allergan is acquiring the rights from Editas Medicine to develop an application of the genome-editing technology Crispr for the inherited eye disease Leber congenital amaurosis type 10.